QH
Therapeutic Areas
CimCure Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CVx1 | Muscle-Invasive Bladder Cancer | Phase 1/2 |
Leadership Team at CimCure
DE
Diederik Engbersen
Chief Executive Officer (CEO)
PA
Prof. Arjan Griffioen
Chief Scientific Officer (CSO)
RP
Raymond Perrenet
Chief Operating Officer (COO)
JV
Joost van Bree
Chief Medical Officer (CMO)
EH
Else Huijbers
Senior Scientist
GS
Gerard Spanbroek
Advisor
MV
Marijke Vendrig
QA/QP (Quality Assurance / Qualified Person)
EB
Emma Bos
Research Technician